BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2024 9:27:23 AM | Browse: 147 | Download: 642
 |
Received |
|
2024-06-05 13:32 |
|
Peer-Review Started |
|
2024-06-05 13:32 |
|
First Decision by Editorial Office Director |
|
2024-08-01 19:25 |
|
Return for Revision |
|
2024-08-01 19:25 |
|
Revised |
|
2024-08-06 11:32 |
|
Publication Fee Transferred |
|
2024-08-16 11:30 |
|
Second Decision by Editor |
|
2024-08-16 04:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-16 09:24 |
|
Articles in Press |
|
2024-08-16 09:24 |
|
Edit the Manuscript by Language Editor |
|
2024-08-28 16:49 |
|
Typeset the Manuscript |
|
2024-08-31 01:49 |
|
Publish the Manuscript Online |
|
2024-09-10 09:27 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical and Translational Research |
| Article Title |
B cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ke-Quan Xu, Zheng Gong, Jia-Ling Yang, Chu-Qi Xia, Jian-Yi Zhao and Xi Chen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xi Chen, PhD, Research Scientist, Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan 430071, Hubei Province, China. chenxi2022@whu.edu.cn |
| Key Words |
B cell; Hepatocellular carcinoma; Immune microenvironment; Immunotherapy; Molecular subtype |
| Core Tip |
We have established a reliable B cell-related genes prognostic model and novel molecular subtypes in hepatocellular carcinoma (HCC). The B cell-related genes model reveals the immune status and personalized treatment options of HCC molecular subtypes B cells may play a role in tumor cytotoxicity by activating cluster of differentiation (CD) 4 + and CD8 + T cells in HCC. |
| Publish Date |
2024-09-10 09:27 |
| Citation |
Xu KQ, Gong Z, Yang JL, Xia CQ, Zhao JY, Chen X. B cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma. World J Gastroenterol 2024; 30(34): 3894-3925 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i34/3894.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i34.3894 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
